Synthesis and anti-HIV activity of GS-9148 (2′-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor

This publication has 28 references indexed in Scilit:

• Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonates
  Bioorganic & Medicinal Chemistry Letters, 2007
• Recent and future therapeutic advances in the management of HIV infection
  Pathologie Biologie, 2006
• Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses
  Antiviral Research, 2006
• Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
  New England Journal of Medicine, 2006
• 'Working at the margins' or 'leading from behind'?: a Canadian study of hospital-community collaboration
  Health & Social Care in the Community, 2005
• Direct, DNA Pol-γ-Independent Effects of Nucleoside Reverse Transcriptase Inhibitors on Mitochondrial Bioenergetics
  Cardiovascular Toxicology, 2004
• Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspective
  Nature Reviews Drug Discovery, 2003
• Structural Determinants in Human DNA Polymerase γ Account for Mitochondrial Toxicity from Nucleoside Analogs
  Journal of Molecular Biology, 2003
• Regiospecific and highly stereoselective electrophilic addition to furanoid glycals: synthesis of phosphonate nucleotide analogs with potent activity against HIV
  The Journal of Organic Chemistry, 1991
• Nucleosides. XV. Decarboxylative elimination of 2'-deoxynucleoside uronic acids
  Journal of the American Chemical Society, 1972